Dayna Isaacs MD MPH (She/Her)

PubMed

• A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy.
  Neeja Patel, Rohan Karanth, Dayna J Isaacs, Joss Cohen, Deborah J Wong
  Cureus. 2024-10-01
• 2 citations
  Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy.
  Dayna Jill Isaacs, Nikhita Kathuria-Prakash, Robin Hilder, Melissa G Lechner, Alexandra Drakaki
  Current Cancer Reports. 2024-02-20
• 6 citations
  Do Cancer Genetics Impact Treatment Decision Making? Immunotherapy and Beyond in the Management of Advanced and Metastatic Urothelial Carcinoma.
  Gavin Hui, Dimitrios Stefanoudakis, Yuliya Zektser, Dayna Jill Isaacs, Christopher Hannigan
  Current Oncology. 2023-08-04

Journal Articles

• Case in point: a veteran presenting with symptomatic postprandial episodes  
  • Isaacs DJ, Tessem RA, Drolen CE, Hernandez EA, Federal Practitioner, 3/1/2025
• A Rare Case of Severe Vitamin D Deficiency Presenting as Diffuse Osteosclerosis  
  Dayna J. Isaacs, Renae A. Tessem, Claire E. Drolen, Estebes A. Hernandez, Annals of Internal Medicine: Clinical Cases, 2/4/2025
• Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy  
  Dayna Jill Isaacs, Nikhita Kathuria-Prakash, Robin Hilder, Melissa G. Lechner, Alexandra Drakaki, Current Cancer Reports, 1/29/2024

Abstracts/Posters

• Are severe immune-related adverse events more likely in patients with preexisting autoimmune disease?
  Isaacs DJ, Hilder R, Drakaki D, Lechner MG, Journal of Clinical Oncology, 2023